Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.

[1]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[2]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[3]  G. Filippatos,et al.  Reframing the association and significance of co‐morbidities in heart failure , 2016, European journal of heart failure.

[4]  M. Pfisterer,et al.  Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction , 2015, European journal of heart failure.

[5]  A. Cittadini,et al.  Hormone replacement therapy in heart failure , 2015, Current opinion in cardiology.

[6]  J. Sanderson Comments on "The management of Heart Failure with preserved ejection fraction" , 2015 .

[7]  R. Napoli,et al.  Multiple hormone deficiencies in chronic heart failure. , 2015, International journal of cardiology.

[8]  A. Coats,et al.  The Management of Heart Failure with Preserved Ejection Fraction (HFpEF) , 2014 .

[9]  P. Gargiulo,et al.  Blockade of β‐adrenoceptors restores the GRK2‐mediated adrenal α2‐adrenoceptor–catecholamine production axis in heart failure , 2012, British journal of pharmacology.

[10]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[11]  G. Limongelli,et al.  The T.O.S.CA. Project: research, education and care. , 2011, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[12]  P. Ponikowski,et al.  Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival , 2006, Circulation.

[13]  R. Napoli,et al.  Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. , 2002, The Journal of clinical endocrinology and metabolism.